Soleno Therapeutics (SLNO) Other Operating Expenses: 2014-2017
Historic Other Operating Expenses for Soleno Therapeutics (SLNO) over the last 4 years, with Dec 2017 value amounting to $1,000.
- Soleno Therapeutics' Other Operating Expenses rose 298.41% to $1,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $4,251, marking a year-over-year decrease of 99.25%. This contributed to the annual value of $3.2 million for FY2024, which is 19.45% up from last year.
- According to the latest figures from Q4 2017, Soleno Therapeutics' Other Operating Expenses is $1,000, which was down 80.00% from $5,000 recorded in Q3 2017.
- Soleno Therapeutics' 5-year Other Operating Expenses high stood at $506,000 for Q2 2015, and its period low was -$94,000 during Q1 2016.
- Over the past 3 years, Soleno Therapeutics' median Other Operating Expenses value was $85,000 (recorded in 2016), while the average stood at $180,672.
- Its Other Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 4,116.67% in 2015, then slumped by 136.15% in 2016.
- Quarterly analysis of 4 years shows Soleno Therapeutics' Other Operating Expenses stood at $156,359 in 2014, then soared by 218.80% to $498,470 in 2015, then slumped by 99.95% to $251 in 2016, then spiked by 298.41% to $1,000 in 2017.
- Its last three reported values are $1,000 in Q4 2017, $5,000 for Q3 2017, and -$2,000 during Q1 2017.